After administration, immuno-switch NPs inhibited PD-L1 signal in tumor cells, and concurrently activated 4-1BB signal in CD8+ T cells, activating immune response against murine colon carcinoma 38 (MC38) in a two-pronged pathway. Here, CD8A is linked to neoplasm.